<TABLE> <S> <C>


<ARTICLE>                                        5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements included in the Form 10-QSB for the quarter ended November
30, 1996 of Endogen, Inc. to which this exhibit is a part and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
<RESTATED>
<MULTIPLIER>                                     1,000
       
<S>                                              <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                                MAY-31-1997
<PERIOD-START>                                   JUN-01-1996
<PERIOD-END>                                     NOV-30-1996
<CASH>                                                                       405
<SECURITIES>                                                                   0
<RECEIVABLES>                                                              1,606
<ALLOWANCES>                                                                  20
<INVENTORY>                                                                1,577
<CURRENT-ASSETS>                                                           3,787
<PP&E>                                                                     2,941
<DEPRECIATION>                                                               849
<TOTAL-ASSETS>                                                             6,709
<CURRENT-LIABILITIES>                                                      1,827
<BONDS>                                                                        0
<PREFERRED-MANDATORY>                                                          0
<PREFERRED>                                                                    0
<COMMON>                                                                      30
<OTHER-SE>                                                                 3,181
<TOTAL-LIABILITY-AND-EQUITY>                                               6,709
<SALES>                                                                    4,704
<TOTAL-REVENUES>                                                           4,704
<CGS>                                                                      1,614
<TOTAL-COSTS>                                                              4,265
<OTHER-EXPENSES>                                                               0
<LOSS-PROVISION>                                                               0
<INTEREST-EXPENSE>                                                           120
<INCOME-PRETAX>                                                              319
<INCOME-TAX>                                                                  50
<INCOME-CONTINUING>                                                          269
<DISCONTINUED>                                                                 0
<EXTRAORDINARY>                                                                0
<CHANGES>                                                                      0
<NET-INCOME>                                                                 269
<EPS-PRIMARY>                                                                .09
<EPS-DILUTED>                                                                .08
        


</TABLE>